This new position paper proposes analyses to better understand the perspectives of French retail pharmacies by 2023.
News
Successfully navigating the Euro-5 orphan drug markets requires a deep understanding of country-specific market access frameworks, HTA...
Developing a strategy for rare diseases in France requires a clear understanding of the care ecosystem, key...
The French Voluntary Trade Organization (VTO) market is consolidating, making VTOs increasingly important partners for pharma companies...